Torrent Group

The Mehta family controls investment decisions through a governance structure where second-generation principals Samir and Sudhir Mehta retain oversight, while third-generation family members execute operating-level capital allocation. Strategic M&A decisions, including the JB Pharma buyout and the Gujarat Titans acquisition, are driven by the family core with professional transaction support.

Torrent Group operates through two publicly listed flagship companies — Torrent Pharmaceuticals (BSE: 500420) and Torrent Power (BSE: 532779) — alongside unlisted entities for newer ventures like the Gujarat Titans franchise. The pharma and power divisions generate the bulk of operating cash flow, which feeds both reinvestment into the core businesses and the family's unlisted investment activities.

The Mehta family's wealth originates from Torrent Pharmaceuticals, founded in 1959 as a small generic-drug manufacturer. The business scaled through branded generic formulations for the domestic Indian market and later expanded into power generation and distribution. The family's current wealth base is concentrated in the listed market capitalizations of Torrent Pharma and Torrent Power, supplemented by real estate holdings and the Gujarat Titans asset.

Torrent Group historically pursued majority or full control positions in its pharmaceutical acquisitions — the Elder Pharma, Unichem, and JB Chemicals transactions were all structured for operating control. In power, the group favors greenfield development. The Gujarat Titans acquisition from CVC Capital Partners also transferred full controlling interest to Torrent, suggesting a persistent preference for control over passive minority stakes.

Torrent has not publicly disclosed an exclusion list, but the observable investment pattern shows no known exposure to financial services, pure-play technology, metals, or heavy industrials. The group concentrates in pharmaceuticals, energy, and — with the Gujarat Titans acquisition — consumer-facing sports media, with no indication of genuine diversification outside these pillars.

Torrent Group does not describe itself as a single family office. It operates as a conglomerate with two major publicly listed operating companies, where the Mehta family holds controlling stakes. While the family treasury makes independent investments — such as the Gujarat Titans — the group's public-market governance and operating-company structure distinguish it from a traditional investment office model.

Torrent transacted with both firms as a buyer. In 2023, it acquired a controlling stake in JB Chemicals & Pharmaceuticals from KKR. In 2025, it acquired a majority stake in the Gujarat Titans IPL franchise from CVC Capital Partners. These were arm's-length acquisitions; neither CVC nor KKR holds a disclosed ongoing partnership or co-investment relationship with Torrent.